SEP 10, 2019 3:33 PM PDT

Does Modafinil Really Increase Brain Function?

WRITTEN BY: Annie Lennon

Modafinil, often sold under the name “Provigil”, is a wakefulness-promoting drug used to treat excessive sleeping in conditions such as narcolepsy and obstructive sleep apnea. However, some also use it as a cognitive enhancer too, to improve focus, memory and executive functioning (ALZ Discovery: 2019). But how does it work? And does it really increase brain power? 

Exactly how modafinil works is unknown. It does however seem to have a significant impact on several neurotransmitters including serotonin and glutamate as well as the brain’s histamine systems, all responsible for regulating mood, learning and memory. In particular, however, it is thought to directly alter the concentration of catecholamines, such as adrenaline and dopamine, in the brain in a way that is thought to enhance one’s capacities for executive functioning and focus (Minzenberg: 2008).

Despite these proposed effects however, studies show that the real effects of modafinil are inconsistent and vary according to the prior health of the user. For example, although a systematic review of studies measuring on the drug’s effects between 1990 and 2014 on healthy individuals demonstrated increased performance in demanding tasks, a more recent study, contradicted these findings. Conducted in 2015 on a cohort of healthy university students in a double-blind, placebo-controlled trial, researchers found that although the drug may have helped the students complete non-demanding tasks, few positive effects were seen on more demanding tasks such as studying (Fernandez: 2015).

Despite this however, more positive results have been found among people with preexisting health issues: in this case; remitted depression. In another double blind, placebo-controlled study from 2017, researchers monitored 60 participants either on a single dose of 200mg of modafinil, or a placebo, for changes in their cognitive functions. Drawing conclusions from both neurocognitive tests and the subjective feelings of the participants during the trial, the researchers found that the modafinil group performed significantly better on tests for episodic memory and working memory. Despite these improvements however, they found that modafinil had little effect on planning or sustained attention (Kaser: 2017). 

Although interesting results, as most of these trials tested only for a single dosage of modafinil, and with no studies having researched its long term usage, further research is necessary to establish more concrete results and expectations for both healthy individuals and those with pre-existing conditions (Loria: 2016). Due to the lack of funding for cognitive enhancement for healthy people however, findings on its specific benefits at least for healthy individuals may continue to originate from either smaller-scale studies or anecdotal evidence.

To conclude, it appears that although modafinil may increase certain aspects of cognitive functioning, its results in healthy people are variable, and appear stronger for those with pre existing issues than for those without. Despite having some awareness of neurological processes the drug effects and interacts with, how exactly the it impacts the brain is still unknown. Thus, even though anecdotal evidence may still encourage usage of modafinil for its cognition-enhancing effects, more research is needed to understand both how exactly it works, and to what extent it works. 

 

Sources

 

ALZ Discovery 

Minzenberg, MJ et al.: Pub Med 

Fernandez, A et al.: Pub Med

Kaser, Muzaffer et al: US National Library of Medicine 

Battleday, RM et al.: US National Library of Medicine 

Loria, Kevin: Business Insider 

About the Author
  • Annie graduated from University College London and began traveling the world. She is currently a writer with keen interests in genetics, psychology and neuroscience; her current focus on the interplay between these fields to understand how to create meaningful interactions and environments.
You May Also Like
NOV 19, 2019
Drug Discovery & Development
NOV 19, 2019
Experimental Cholesterol-Lowering Drug
A recent study shows that patients who take a maximum dose of statin drugs in addition to a twice-yearly injection of the experimental cholesterol-lowering...
NOV 24, 2019
Drug Discovery & Development
NOV 24, 2019
The Fight Against Lethal Childhood Brain Cancers
Scientists used studies on cell and animal models to reveal insights into lethal childhood brain cancers and find promising drug therapeutics. The deadly c...
DEC 04, 2019
Neuroscience
DEC 04, 2019
Single Dose Ketamine Could Rewire Alcohol, Drug Dependance
Presentation by Tobias Stephenson about previous research exploring ketamine as an addiction treatment.    Researchers at University College Lond...
DEC 23, 2019
Cell & Molecular Biology
DEC 23, 2019
An Antioxidant Found in Green Tea Can Fight Tuberculosis
In 2018, around ten million people around the globe were sickened by tuberculosis (TB) and about 1.5 million people were killed by tuberculosis....
DEC 27, 2019
Drug Discovery & Development
DEC 27, 2019
Acne Drug Linked to 10 Suicides
UK regulators claim to have found a link between at least ten suicides and a powerful acne drug, manufactured under the names Roaccutane and Accutane. Alth...
FEB 06, 2020
Drug Discovery & Development
FEB 06, 2020
Potential Cure for Coronavirus Found in Thailand
Doctors in Thailand have successfully treated people affected by the coronavirus via a new drug cocktail made out of antiviral, flu and HIV medication. Alt...
Loading Comments...